The use of a chromogenic assay for factor VIII in patients with factor VIII inhibitors or von Willebrand's disease.
Hutton
R A
RA
Haemophilia Centre, Royal Free Hospital, London, UK.
Kamiguti Yamaga
A
A
Matthews
K B
KB
Woodhams
B J
BJ
D001323:Autoantibodies / Q000097:blood; D001681:Biological Assay / Q000379:methods; D001774:Blood Chemical Analysis / Q000379:methods*; D002863:Chromogenic Compounds; D005069:Evaluation Studies as Topic; D005169:Factor VIII / Q000032:analysis* / Q000037:antagonists & inhibitors / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D014842:von Willebrand Diseases / Q000097:blood*
D001323:Autoantibodies; D002863:Chromogenic Compounds; D005169:Factor VIII